Stay updated with breaking news from Viral Evolution. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Nature article details how the NIH SAVE program helps inform COVID-19 pandemic policy worldwideNEW YORK, NY / ACCESSWIRE / April 26, 2022 / Dr. Anthony Fauci, Director of the National Institute of Allergy
“The Committee recognized that SARS-CoV-2 is a novel respiratory pathogen that has not yet established its ecological niche. SARS-CoV-2 continues to have unpredictable viral evolution, which is compounded by its wide-spread circulation and intense transmission in humans
Our best chance of limiting the emergence of new recombinant COVID variants is to limit the spread of infections, using public health measures to slow and suppress the virus.
The University of California San Diego has joined a Phase II clinical trial to evaluate various additional COVID-19 booster shots. The trial seeks to understand if different vaccine regimens can broaden immune responses in adults who already have received a primary vaccination series and a first booster shot.
The SAVE initiative assesses the impact of SARS-CoV-2 variants on diagnostics, vaccines, and therapies, as well as communicating public health dangers.